Eurasian Patent Organization

organization

Last mentioned: Mar 17, 2026

Timeline

  1. Bioequivalence Studies

    Projected commencement of studies required for regional regulatory filings.

  2. Strategic Agreement Signed

    BioNxt announces a commercialization deal for Cladribine ODF in the Eurasian region.

  3. Patent Grants Confirmed

    Patents for the ODF formulation are officially granted in Europe and Eurasia.

Stories mentioning Eurasian Patent Organization 1

pharma Bullish

BioNxt Secures Eurasian Commercialization Deal for Cladribine ODF

BioNxt Solutions has entered a strategic partnership to commercialize its Cladribine Oral Dissolvable Film (ODF) across Eurasia, following successful patent approvals in both Europe and the Eurasian region. This move positions the company to capture market share in the Multiple Sclerosis (MS) treatment space with a novel, patient-friendly delivery mechanism.

2 sources